A detailed history of Rothschild Investment LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 27 shares of CTLT stock, worth $1,617. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27
Previous 27 -0.0%
Holding current value
$1,617
Previous $1.52 Million 7.71%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$53.58 - $57.02 $1,446 - $1,539
27 New
27 $1.52 Million
Q1 2024

Jul 31, 2024

BUY
$42.56 - $59.82 $851 - $1,196
20 Added 74.07%
47 $2.65 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.8B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.